Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Wilms Tumor 1Sarcoma 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Kidney Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Cyclophosphamide 5fludarabine phosphate 4Mycophenolic Acid 4Filgrastim 4Carboplatin 4Whole-Body Irradiation 3Thiotepa 3Cyclosporine 3Busulfan 3Voriconazole 2Therapeutics 2Polymerase Chain Reaction 2Methylprednisolone 2Methotrexate 2Melphalan 2Itraconazole 2Flow Cytometry 2Etoposide 2Carmustine 2Antilymphocyte Serum 2Amplified Fragment Length Polymorphism Analysis 2sargramostim 1liposomal amphotericin B 1glutamic acid diethyl ester 1etoposide phosphate 1alvocidib 1aldesleukin 1Valacyclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × Glutamine × Genitourinary × Clear all
NCT00365768 2016-09-09

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Columbia University

Phase 2 Completed
56 enrolled 5 charts
GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Neurotoxicity Syndromes, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡